IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Sai Life Sciences Ltd.
Issue Open Date 11-Dec-24  
Issue Closing Date 13-Dec-24  
Application Money 100  
Allotment Money  
Price Band 522 - 549  
Minimium Application No. 27  
Issue Size (Shares) 38829848  
Market Lot 1.00  
Objective
1. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company; and2. General corporate purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   8447426   41522058   4.92  
Qualified Institutional Buyers   10671763   330125058   30.93  
Retail Individual Investors   19710659   26912412   1.37  
Business Description
We are an innovator-focused, contract research, development, and manufacturing organization (“CRDMO”). We provide end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (“NCE”), to gl
more...
Promoter's Holding
Total Share Capital   77704340  
Offered to Public   38829848  
Promoter's Holding (Pre-Issue)   40.48  
Promoter's Holding (Post-Issue)   35.24  
Address
Plot No. D S-7
I K P Knowledge Park
Turkapally Village
Shameerpet Mandal
Medchal- Malkajgiri District
Hyderabad ,
Telangana ,
500078
Phone: 040-68156000
Email: investors@sailife.com
Website: www.sailife.com
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
IIFL Securities Ltd.
Jefferies India Pvt Ltd.
Kotak Mahindra Capital Co Ltd
Morgan Stanley India Co Pvt Ltd
Promoters
Kanumuri Mytreyi
Kanumuri Ranga Raju
Krishnam Raju Kanumuri
Marigold Partners
Sai Quest Syn Pvt Ltd.
Sunflower Partners
Tulip Partners and Lily Partners
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.